We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.07%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.05B
AUM Growth
+$503M
(+14%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
8.14%
Top 10 Holdings %
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155
Avg Time Held Equity + Options
4.2
quarters
Top 10 Avg Time Held Equity + Options
1.2
quarters
Top 20 Avg Time Held Equity + Options
1.3
quarters
Avg Time Held Equity only
4.5
quarters
Top 10 Avg Time Held Equity only
1.2
quarters
Top 20 Avg Time Held Equity only
1.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$269M |
| 2 |
Stericycle Inc
SRCL
|
+$141M |
| 3 |
Marathon Oil Corporation
MRO
|
+$108M |
| 4 |
ChampionX
CHX
|
+$103M |
| 5 |
Spirit AeroSystems
SPR
|
+$95.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitrans Midstream Corporation Common Stock
ETRN
|
+$149M |
| 2 |
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$81.8M |
| 3 |
Southwestern Energy Company
SWN
|
+$56.7M |
| 4 |
Union Pacific
UNP
|
+$24.2M |
| 5 |
US Steel
X
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 20.91% |
| 2 | Technology | 19.62% |
| 3 | Healthcare | 14.36% |
| 4 | Industrials | 11.13% |
| 5 | Consumer Staples | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
PUT
FirstEnergy
FE
$26B
| $27.3K | ﹤0.01% |
26,000
| – | – |
2024 Q2
1 quarter
|
|
427
DELISTED
DigiAsia Corp Warrant
FAASW
| $27.1K | ﹤0.01% |
135,667
-2,994
| -2% | -$287 |
2023 Q1
6 quarters
|
|
428
CALL
Rhythm Pharmaceuticals
RYTM
$6.25B
| $26K | ﹤0.01% |
+20,000
| New | +$958K |
2024 Q3
0 quarters
|
|
429
CALL
Medtronic
MDT
$113B
| $25.6K | ﹤0.01% |
+25,000
| New | +$2.1M |
2024 Q3
0 quarters
|
|
|
VRNA
430
CALL
DELISTED
Verona Pharma
VRNA
| $25.6K | ﹤0.01% |
25,000
-15,000
| -38% | -$369K |
2024 Q2
1 quarter
|
|
431
PUT
Vaxcyte
PCVX
$10.6B
| $25K | ﹤0.01% |
10,000
| – | – |
2024 Q2
1 quarter
|
|
432
CALL
GE HealthCare
GEHC
$29.7B
| $23.5K | ﹤0.01% |
+20,000
| New | +$1.68M |
2024 Q3
0 quarters
|
|
433
DELISTED
USA Rare Earth Inc Warrant
USARW
| $22.6K | ﹤0.01% |
100,248
-3,238
| -3% | -$552 |
2023 Q4
3 quarters
|
|
434
CALL
Black Diamond Therapeutics
BDTX
$105M
| $22.5K | ﹤0.01% |
300,000
+253,600
| +547% | +$1.38M |
2024 Q2
1 quarter
|
|
435
PUT
GSK
GSK
$93.2B
| $22.5K | ﹤0.01% |
+50,000
| New | +$2.05M |
2024 Q3
0 quarters
|
|
436
PUT
DELISTED
Tri Pointe Homes
TPH
| $22.2K | ﹤0.01% |
24,700
| – | – |
2024 Q2
1 quarter
|
|
437
CALL
Sanofi
SNY
$96B
| $20.3K | ﹤0.01% |
15,000
-15,000
| -50% | -$810K |
2024 Q2
1 quarter
|
|
438
CALL
Edgewise Therapeutics
EWTX
$4.24B
| $20.1K | ﹤0.01% |
+35,000
| New | +$696K |
2024 Q3
0 quarters
|
|
439
CALL
Amgen
AMGN
$224B
| $20K | ﹤0.01% |
+10,000
| New | +$3.27M |
2024 Q3
0 quarters
|
|
440
CALL
Ultragenyx Pharmaceutical
RARE
$1.53B
| $20K | ﹤0.01% |
25,000
-15,000
| -38% | -$764K |
2023 Q2
5 quarters
|
|
441
CALL
Syndax Pharmaceuticals
SNDX
$1.52B
| $18.8K | ﹤0.01% |
+50,000
| New | +$1.03M |
2024 Q3
0 quarters
|
|
442
PUT
Sinclair Inc
SBGI
$921M
| $16.4K | ﹤0.01% |
109,400
| – | – |
2024 Q2
1 quarter
|
|
443
PUT
XPLR Infrastructure LP
XIFR
$978M
| $16.3K | ﹤0.01% |
27,100
| – | – |
2023 Q3
4 quarters
|
|
444
CALL
Alphatec Holdings
ATEC
$1.65B
| $15.8K | ﹤0.01% |
70,000
+30,000
| +75% | +$230K |
2024 Q2
1 quarter
|
|
445
CALL
Establishment Labs
ESTA
$1.84B
| $15K | ﹤0.01% |
+20,000
| New | +$870K |
2024 Q3
0 quarters
|
|
446
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
| $14.7K | ﹤0.01% |
209,630
-4,805
| -2% | -$226 |
2023 Q4
3 quarters
|
|
447
CALL
Wave Life Sciences
WVE
$682M
| $13.8K | ﹤0.01% |
+50,000
| New | +$299K |
2024 Q3
0 quarters
|
|
|
KDKRW
448
Kodiak AI Warrants
KDKRW
| $13.6K | ﹤0.01% |
82,711
-2,672
| -3% | -$347 |
2023 Q4
3 quarters
|
|
449
CALL
Relay Therapeutics
RLAY
$3.92B
| $12.5K | ﹤0.01% |
+110,000
| New | +$822K |
2024 Q3
0 quarters
|
|
450
PUT
Navient
NAVI
$854M
| $12.4K | ﹤0.01% |
16,500
| – | – |
2021 Q2
13 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2024 Portfolio in Review
As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
UBS O'Connor deployed $330M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.
By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.
- UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
- UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
- UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
- UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
- UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
- UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
- UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.
Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.